Oscient Pharmaceuticals Provides Preliminary Revenue Results for the Second Quarter of 2007 Total revenues increase more than 200% over Q2 2006 reflecting ANTARA(R) acquisition WALTHAM, Mass., Jul …
Die kennen zu viele, und zwar als Negativerlebniss. :laugh: